Effect of Omega 3 Fatty Acids on Vascular Function
NCT01888211 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20
Last updated 2024-05-01
Summary
The mechanisms through which omega-3 fatty acids reduce adverse cardiac events remain uncertain. The aim of the study was to investigate the effect of omega-3 fatty acid supplementation on endothelial vasomotor function, endogenous fibrinolysis, and platelet and monocyte activation in patients with coronary heart disease.
Conditions
- Previous Myocardial Infarction
Interventions
- DIETARY_SUPPLEMENT
-
Omega 3 fatty acid supplementation
2 grams Omacor daily
- DIETARY_SUPPLEMENT
-
Olive Oil
2 grams olive oil daily
Sponsors & Collaborators
-
University of Edinburgh
lead OTHER
Principal Investigators
-
David E Newby · University of Edinburgh
-
Jehangir N Din · University of Edinburgh
Study Design
- Allocation
- RANDOMIZED
- Purpose
- OTHER
- Masking
- DOUBLE
- Model
- CROSSOVER
Eligibility
- Min Age
- 18 Years
- Sex
- MALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-12-31
- Primary Completion
- 2006-06-30
- Completion
- 2009-06-30
Countries
- United Kingdom
Study Locations
More Related Trials
-
Omega-3 Fatty Acids Supplementation and Atherothrombotic Biomarkers in Type 2 Diabetes and Cardiovascular Disease.
NCT02178501 ·Status: COMPLETED ·Phase: NA
-
The Triglyceride Lowering Effect of an Omega-3 Fat (DHA) in Addition to Statin Therapy for Patients With CAD or Diabetes
NCT00360217 ·Status: COMPLETED ·Phase: NA
-
Omega 3 Action on Cardiovascular Risk Factors in Patients Treated With Statins
NCT00976872 ·Status: COMPLETED ·Phase: NA
-
The Impact of Fish-oil Fatty Acids on Postprandial Vascular Reactivity
NCT01692431 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Fatty Acids on Markers of Inflammation
NCT01129050 ·Status: COMPLETED ·Phase: NA
-
Fish Oil and Cardiovascular Suboptimal Health
NCT02103517 ·Status: COMPLETED ·Phase: PHASE3
-
Short Term Omega-3 Supplementation on Performance
NCT02014233 ·Status: COMPLETED ·Phase: NA
-
The Effect of Omega-3 Supplementation on Muscle Functioning, Inflammation and Muscle Signaling
NCT03986307 ·Status: COMPLETED ·Phase: NA
-
Effects of High-dose n-3 Fatty Acids on Clinical Outcome and Serum Lipids - Omacor Following Acute Myocardial Infarction
NCT01422317 ·Status: COMPLETED ·Phase: PHASE3
-
Investigating the Effect of 4-week Omega-3 Polyunsaturated Fatty Acid Supplementation on Inflammation
NCT03210805 ·Status: UNKNOWN ·Phase: NA
-
Cardiometabolic Benefits of Omega-3 Polyunsaturated Fatty Acids
NCT03378232 ·Status: COMPLETED ·Phase: NA
-
Omega-3 Fatty Acids, the Omega-3 Index, and Atherosclerosis
NCT00886704 ·Status: COMPLETED ·Phase: NA
-
Potential Effects of Omega 3 Supplementation on Cardiomyocytes Membranes for Patients With Coronary Atherosclerosis?
NCT01699230 ·Status: UNKNOWN ·Phase: PHASE3
-
Omega-3 to Reduce Diabetes Risk in Subjects With High Number of Particles That Carry "Bad Cholesterol" in the Blood
NCT04496154 ·Status: COMPLETED ·Phase: NA
-
Effect of High Dose Fish Oil Supplementation After Recent Heart Attack Using Magnetic Resonance Imaging
NCT00729430 ·Status: COMPLETED ·Phase: PHASE3
-
Erythrocyte Omega-3 Fatty Acid Content in Elite Athletes
NCT02610270 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Evaluating the Effects of Omega-3 Fatty Acids on Heart Disease and Behavior
NCT00663871 ·Status: COMPLETED ·Phase: NA
-
Effect of Combined Fatty Acid Supplementation and Eccentric Exercise Training on Exercise Performance
NCT03259412 ·Status: COMPLETED ·Phase: NA
-
Omega 3 Fatty Acids and Atrial Fibrillation
NCT00508248 ·Status: WITHDRAWN ·Phase: NA
-
Vascular Impact of Omega-3 in Metabolic Syndrome
NCT01566188 ·Status: COMPLETED ·Phase: NA
-
Effects of Omega-3 Fatty Acids and Menaquinone-7 on Thrombotic Tendency
NCT00732576 ·Status: COMPLETED ·Phase: NA
-
The Effect Of Omega-3 Fatty Acids on Non-alcoholic Fatty Liver Disease
NCT01277237 ·Status: COMPLETED ·Phase: PHASE3
-
Dietary Omega-7 Palmitoleic Acid-Rich Oil on Lipoprotein Metabolism and Satiety in Adults
NCT03372733 ·Status: RECRUITING ·Phase: PHASE2
-
Intake of Omega 3 in Morbidly Obese Patients
NCT02113696 ·Status: COMPLETED ·Phase: NA
-
Fatty Acid Metabolism in Carriers of Apolipoprotein E Epsilon 4 Allele: Determining the Blood-to-brain Link
NCT04279743 ·Status: UNKNOWN ·Phase: NA